Secure Cloud Platforms Strengthen Pharmaceutical Data Management

The global cloud computing in pharmaceutical market is transforming pharmaceutical operations through internet-based infrastructure for data storage, processing, management, and application access. Pharmaceutical companies are adopting cloud platforms to improve research collaboration, clinical trial management, manufacturing operations, regulatory documentation, and supply chain coordination. Demand for scalable digital infrastructure, centralized pharmaceutical data management, and secure research environments is supporting cloud adoption across drug discovery, clinical development, and pharmaceutical manufacturing.

The global cloud computing in pharmaceutical market size was valued at USD 20.97 billion in 2025 and is projected to grow from USD 24.03 billion in 2026 to USD 71.49 billion by 2034, registering a CAGR of 14.6% during the forecast period from 2026 to 2034. North America dominated the market with a 41.5% share in 2025.

For detailed market insights, growth forecasts, and competitive analysis, visit:https://straitsresearch.com/report/cloud-computing-in-pharmaceutical-industry-market

Market Drivers

Digitalization of Pharmaceutical Manufacturing and Quality Control Drives Market

Pharmaceutical manufacturers are adopting digital systems to manage production records, quality inspections, equipment performance, and manufacturing workflows. Cloud computing provides centralized access to production data and supports coordination between manufacturing facilities, quality teams, and regulatory departments. Cloud-based manufacturing systems also help companies monitor batch production records and quality-control information across multiple facilities. These capabilities support demand for cloud infrastructure that connects manufacturing operations and improves production data accessibility.

Centralized Pharmaceutical Data Management Requirements Drive Market

Pharmaceutical operations generate substantial volumes of research, production, regulatory, and commercial data that require organized storage and controlled access. Cloud platforms allow companies to consolidate information from different departments and facilities while supporting data sharing and operational coordination. Centralized storage also helps pharmaceutical organizations manage distributed operations and maintain consistent access to business-critical information. These requirements are encouraging investment in scalable cloud services and enterprise data management platforms.

Electronic Batch Records and Digital Documentation Drive Market

Pharmaceutical companies are adopting electronic batch records and digital documentation systems to improve production traceability and audit preparation. Cloud-based platforms allow manufacturing teams and quality departments to access batch information and production records across different facilities. Digital documentation also supports information exchange and controlled access to manufacturing data. These applications are supporting the adoption of cloud services across regulated pharmaceutical production environments.

Market Challenges

The report does not provide a dedicated market restraints or challenges analysis. It identifies data security, regulatory compliance, and data integrity as important considerations for pharmaceutical cloud adoption. These factors should be evaluated by pharmaceutical companies when selecting cloud infrastructure and deployment models.

Market Trends

Adoption of Cloud-Based Real-World Evidence Platforms

The need for broader patient insights and efficient clinical research is encouraging pharmaceutical companies to adopt cloud-based real-world evidence platforms. These systems integrate electronic health records, clinical data, and patient information from multiple sources to support evidence generation and treatment evaluation. The U.S. Food and Drug Administration's Sentinel Initiative uses a distributed data network covering more than 100 million patients to support safety monitoring and regulatory research through real-world healthcare data.

Secure Cloud Environments for Genomic and Precision Medicine Research

Pharmaceutical companies and research institutions are developing secure cloud environments to process large genomic datasets while protecting sensitive patient information. These platforms support scalable genomic analysis, controlled data access, and collaboration among researchers. The National Institutes of Health's AnVIL platform provides a cloud-based environment for analyzing genomic and biomedical datasets while supporting controlled access to sensitive research information.

Market Segmentation

The cloud computing in pharmaceutical market is segmented by service type, deployment mode, and application. By service type, the market includes Software-as-a-Service (SaaS), Infrastructure-as-a-Service (IaaS), and Platform-as-a-Service (PaaS). SaaS dominated with a 54.3% share in 2025, supported by its use in pharmaceutical data management, clinical operations, regulatory compliance, and business process automation. PaaS is projected to grow at a CAGR of 18.3% during the forecast period, driven by application development, data integration, and customized pharmaceutical technology solutions. By deployment mode, the market includes public cloud, private cloud, and hybrid cloud. Public cloud held a 46.8% share in 2025, owing to its scalability, cost efficiency, and accessibility. Hybrid cloud is expected to grow at a CAGR of 19.1% during the forecast period, fueled by the need to combine public cloud scalability with private infrastructure for sensitive pharmaceutical data and regulated workloads. By application, the market includes Production Management System (PMS), Electronic Medical Records (EMR), online sales, and others. PMS dominated with a 34.7% share in 2025, supported by its role in manufacturing coordination, production planning, inventory control, and process monitoring. Online sales is projected to grow at a CAGR of 18.5% during the forecast period, driven by digital sales channels, online ordering platforms, and cloud-based customer management solutions.

Regional Insights

North America dominated the cloud computing in pharmaceutical market with a 41.5% share in 2025. The region benefits from established cloud infrastructure, pharmaceutical technology investments, and digital research initiatives. In the U.S., Merck's strategic collaboration with Google Cloud involves an investment valued at up to USD 1 billion to deploy an AI-enabled enterprise platform across research and development, manufacturing, commercial, and corporate operations. In Canada, the federal government's USD 100 million investment in the VITAL platform is strengthening healthcare data infrastructure by connecting hospital data to support research, healthcare services, and medical innovation.

Asia Pacific is projected to be the fastest-growing region, registering a CAGR of 19.6% during the forecast period, showcasing the fastest-growing regional market. In Japan, digital initiatives involving Fujitsu and IBM Japan are supporting secure cloud infrastructure and integrated healthcare data platforms for pharmaceutical research and AI-based analytics. In China, Alibaba Cloud and Tencent's iDrug support molecular simulations, virtual compound screening, drug candidate evaluation, and research data analysis. In India, Dr. Reddy's Laboratories uses Amazon Web Services (AWS) to manage enterprise applications, manufacturing processes, and digital operations across geographically distributed facilities.

Europe is projected to register a CAGR of 15.4% during the forecast period. Cloud-based life sciences platforms and sovereign computing infrastructure are supporting pharmaceutical research and clinical data management. In the U.K., Oracle provides cloud solutions for clinical trial management, pharmacovigilance, research data integration, and regulatory workflows. In Germany, Deutsche Telekom and T-Systems' industrial AI cloud provides sovereign computing infrastructure for pharmaceutical and biotechnology research. Its collaboration with Apheris also supports the analysis of distributed hospital data while maintaining patient information at its original location.

Key Players Analysis

The cloud computing in pharmaceutical market is moderately consolidated, with global cloud service providers, enterprise software companies, IT infrastructure manufacturers, and healthcare technology providers. Major companies compete through infrastructure capabilities, data security, regulatory compliance, scalability, enterprise integration, and technological innovation. The five leading companies identified in the report's competitive landscape include:

• Microsoft Corporation
• Amazon.com, Inc.
• International Business Machines Corporation (IBM)
• Oracle Corporation
• Google LLC

Established providers focus on enterprise cloud infrastructure, secure data management, pharmaceutical-specific applications, and AI-enabled research capabilities. Emerging and specialized providers compete through customized services, flexible deployment models, cost-effective solutions, and healthcare-focused technologies.

Conclusion

The cloud computing in pharmaceutical market is projected to record strong growth through 2034 as pharmaceutical companies adopt scalable infrastructure for research, manufacturing, clinical operations, and regulatory data management. North America holds the leading market position, while Asia Pacific is expected to record the fastest growth. SaaS and public cloud currently account for the largest shares in their respective segments, whereas hybrid cloud and online sales represent notable growth areas. Continued investment in AI-enabled platforms, secure genomic data environments, and centralized pharmaceutical systems will shape the industry's future.

About Us

Straits Research provides market intelligence, industry analysis, market forecasts, and competitive assessments across global industries. Its research helps organizations understand market dynamics, identify opportunities, and make informed strategic decisions.

Contact Us

Website: https://straitsresearch.com

Email: [email protected]

U.S.: +1 646 905 0080

India: +91 8087085354

U.K.: +44 203 695 0070